Ive been aware of the problems of bacterial resistance for some time. I was expecting this show to be more of the same. There is that but there's a new problem. There's diminishing incentive to make new ones: http://www.pbs.org/wgbh/pages/frontline/hunting-the-nightmare-bacteria/ Drug companies across the board are abandoning antibiotic development. Not because it wont yield new drugs, but because it doesnt make economic sense. Antibiotics dont cost less to create than other drugs, but because their use is limited (by design and necessity), potential sales are also limited. Even a successful new antibiotic can be a big money looser.